Search results
Results From The WOW.Com Content Network
Athersys (ATHX) gains on encouraging results from its exploratory study on the intravenous administration of MultiStem cell therapy to treat patients suffering from ARDS.
Many investors define successful investing as beating the market average over the long term. But the risk of stock...
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. [ 2] It also supplies assorted biomedical products, outsourcing services, and animals ...
Alleghany Corporation. Alleghany Corporation is an American investment holding company originally created by the railroad entrepreneurs Oris and Mantis Van Sweringen as a holding company for their railroad interests. It was incorporated in 1929 [ 2] and reincorporated in Delaware in 1984. [ 3] On March 21, 2022, Berkshire Hathaway made an $11.6 ...
For premium support please call: 800-290-4726 more ways to reach us
1. 2015. Pfizer. Allergan, plc. 160. 206. In November 2015 Pfizer announced it would acquire Allergan, plc for $160 billion ($206 billion, adjusted for inflation). However, this deal was cancelled in April 2016 due to new US tax inversion rules. [ 12][ 13] Had this transaction been completed, this would have been the largest within this industry.